Our history

VaxEquity was founded in 2020 by Imperial College London’s Professor Robin Shattock and Morningside

VaxEquity was founded in 2020 by Imperial College London’s Professor Robin Shattock, and specialist life sciences investor Morningside, and is led by a world class team who are RNA pioneers. The Company is based in Cambridge, UK, and is collaborating with AstraZeneca to progress its platform across multiple disease areas.

Contact us

We are incredibly ambitious and we’re looking for equally ambitious people to join us on this journey to lead the world in realising the full potential of RNA in human health

SB2 4030

Get in touch

Thank you for your message

We have recieved your message and will get back to your shortly.